Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Shi

Showing results (1411-1420 of 1,428) with videos related to

Pageof 143
Sort By:
ACS Medicinal Chemistry Letters|March 21, 2019
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672Michael G Yang, Zili Xiao, Robert J Cherney, et al.
Journal for Immunotherapy of Cancer|July 4, 2024
Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinationsJane E Willoughby, Lang Dou, Sabyasachi Bhattacharya, et al.
Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 2, 2025
Quantification of brain tissue injury and prediction of prognosis using serum GFAP and UCH-L1: A multicenter prospective cohort studyZhen-Ni Guo, Yang Qu, Reziya Abuduxukuer, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical TrialsT G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Medchemcomm|August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulatorsDavid Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Molecular Biology and Evolution|January 9, 2016
A Genetic Mechanism for Convergent Skin Lightening during Recent Human EvolutionZhaohui Yang, Hua Zhong, Jing Chen, et al.
The Lancet. Gastroenterology & Hepatology|March 17, 2023
Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective studyYe Gao, Lei Xin, Han Lin, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
American Journal of Human Genetics|February 16, 2023
Deficiency of primate-specific SSX1 induced asthenoteratozoospermia in infertile men and cynomolgus monkey and tree shrew modelsChunyu Liu, Wei Si, Chaofeng Tu, et al.
Pageof 143

Showing results (1411-1420 of 1,428) with videos related to

Sort By:
Pageof 143
ACS Medicinal Chemistry Letters|March 21, 2019
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672Michael G Yang, Zili Xiao, Robert J Cherney, et al.
Journal for Immunotherapy of Cancer|July 4, 2024
Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinationsJane E Willoughby, Lang Dou, Sabyasachi Bhattacharya, et al.
Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 2, 2025
Quantification of brain tissue injury and prediction of prognosis using serum GFAP and UCH-L1: A multicenter prospective cohort studyZhen-Ni Guo, Yang Qu, Reziya Abuduxukuer, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical TrialsT G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Medchemcomm|August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulatorsDavid Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Molecular Biology and Evolution|January 9, 2016
A Genetic Mechanism for Convergent Skin Lightening during Recent Human EvolutionZhaohui Yang, Hua Zhong, Jing Chen, et al.
The Lancet. Gastroenterology & Hepatology|March 17, 2023
Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective studyYe Gao, Lei Xin, Han Lin, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
American Journal of Human Genetics|February 16, 2023
Deficiency of primate-specific SSX1 induced asthenoteratozoospermia in infertile men and cynomolgus monkey and tree shrew modelsChunyu Liu, Wei Si, Chaofeng Tu, et al.
Pageof 143